Taysha Gene Therapies, Inc. (TSHA) Financial Statements
Taysha Gene Therapies, Inc. (TSHA) reported trailing twelve-month revenue of $5.5M (down 32.3% year on year) and net income of -$149.6M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$132.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TSHATaysha Gene Therapies, Inc.Follow TSHA — free
—
Price chart with a free account
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 2.5 | 15.5 | 8.3 | 9.8 | 5.5 | |
| Gross profit | — | 14.4 | 3.5 | — | — | |
| Research & development | 91.2 | 56.8 | 66.0 | 86.4 | 123.1 | |
| Operating income | -162.4 | -72.4 | -91.5 | -110.5 | -153.2 | |
| Pre-tax income | -166.0 | -111.6 | -89.3 | -109.0 | -149.6 | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net income | -166.0 | -111.6 | -89.3 | -109.0 | -149.6 | |
| Diluted EPS ($) | -3.78 | -0.96 | -0.36 | -0.34 | -0.41 | |
| Diluted shares (mn) | 44.0 | 116.1 | 250.1 | 319.7 | — |
USD millions · SEC XBRL
Taysha Gene Therapies, Inc. — questions
- What is Taysha Gene Therapies, Inc.'s revenue?
- $5.5M over the twelve months to 2026-06-30, down 32.3% year on year, from its 10-Q and 10-K filings.
- What is Taysha Gene Therapies, Inc.'s net income?
- -$149.6M over the twelve months to 2026-06-30.
- What is Taysha Gene Therapies, Inc.'s free cash flow?
- -$132.6M over the twelve months to 2026-06-30.
- What are Taysha Gene Therapies, Inc.'s diluted earnings per share?
- $-0.41 over the twelve months to 2026-06-30.
Every figure on this page comes from Taysha Gene Therapies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.